Published in World J Gastroenterol on September 14, 2006
Tumor immunoediting and immunosculpting pathways to cancer progression. Semin Cancer Biol (2007) 1.55
Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world. J Clin Microbiol (2010) 1.01
The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol (2010) 0.92
Helicobacter pylori in dental plaque and stomach of patients from Northern Brazil. World J Gastroenterol (2010) 0.92
Association of IL1B -511C/-31T haplotype and Helicobacter pylori vacA genotypes with gastric ulcer and chronic gastritis. BMC Gastroenterol (2010) 0.90
Incidence and mortality trends of gastric and colorectal cancers in Croatia, 1988-2008. Croat Med J (2012) 0.87
Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer. Sci Rep (2014) 0.85
ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status. World J Gastroenterol (2015) 0.84
Matrix metalloproteinase-3 promoter polymorphisms but not dupA-H. pylori correlate to duodenal ulcers in H. pylori-infected females. BMC Microbiol (2010) 0.84
Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders. Cancer (2009) 0.82
Contribution of toll-like receptor signaling pathways to breast tumorigenesis and treatment. Breast Cancer (Dove Med Press) (2013) 0.81
Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: a case-control study in Iran. Gastroenterol Hepatol Bed Bench (2012) 0.81
Reduced FAF1 Expression and Helicobacter Infection: Correlations with Clinicopathological Features in Gastric Cancer. Gastroenterol Res Pract (2012) 0.80
Histamine and histamine receptor regulation of gastrointestinal cancers. Transl Gastrointest Cancer (2012) 0.80
Positive selection on a bacterial oncoprotein associated with gastric cancer. Gut Pathog (2011) 0.80
Downregulation of Id1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway. Mol Med Rep (2012) 0.79
Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease. J Clin Invest (2007) 0.76
Serum selenium level in patients with gastric non-cardia cancer and functional dyspepsia. Iran J Med Sci (2015) 0.75
Gastric carcinomas localized to the cardia. Gastroenterol Res Pract (2012) 0.75
Ecological study of gastric cancer in Brazil: geographic and time trend analysis. World J Gastroenterol (2014) 0.75
Helicobacter pylori infection and the development of gastric cancer. N Engl J Med (2001) 17.13
Helicobacter pylori infection. N Engl J Med (2002) 14.81
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Helicobacter pylori virulence and genetic geography. Science (1999) 7.64
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA (2004) 6.96
Helicobacter pylori persistence: biology and disease. J Clin Invest (2004) 4.75
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 4.55
Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology (2003) 4.52
Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12
Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med (2000) 4.09
Gastric cancer. Lancet (2003) 3.96
Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer (2004) 3.88
The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol (2000) 3.79
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res (1998) 3.22
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63
Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest (2001) 2.58
Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther (2002) 2.50
Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32
Epidemiology of gastric cancer in Japan. Postgrad Med J (2005) 2.24
Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol (2004) 1.96
H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol (2002) 1.88
Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology (2001) 1.87
Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis (2003) 1.80
Association between diversity in the Src homology 2 domain--containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis (2004) 1.78
The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature (2001) 1.71
Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol (2004) 1.70
Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res (2001) 1.67
Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population. Cancer Lett (2004) 1.56
Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer (2003) 1.55
Helicobacter pylori and gastric inflammation. Br Med Bull (1998) 1.49
Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology (2000) 1.42
Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer (2005) 1.37
The Helicobacter pylori blood group antigen-binding adhesin facilitates bacterial colonization and augments a nonspecific immune response. J Immunol (2002) 1.34
Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut (2003) 1.22
Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol (2004) 1.21
Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer (2000) 1.18
Negative selection of T cells by Helicobacter pylori as a model for bacterial strain selection by immune evasion. J Immunol (2001) 1.17
Gastric mucosal cytokine and epithelial cell responses to Helicobacter pylori infection in Mongolian gerbils. J Pathol (2004) 1.15
Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis (2002) 1.14
Germ-line p53-targeted disruption inhibits helicobacter-induced premalignant lesions and invasive gastric carcinoma through down-regulation of Th1 proinflammatory responses. Cancer Res (2002) 1.14
Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol (2004) 1.13
Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan. J Clin Microbiol (2004) 1.12
Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii. J Infect Dis (2005) 1.07
Genetic differences in interleukin-1 betapolymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res (2003) 1.06
Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer (2005) 1.02
Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion. J Clin Pathol (2001) 1.00
Gastritis and gastric cancer. Western countries. Gastroenterol Clin North Am (2000) 0.96
Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol (2002) 0.93
Risks of interleukin-1 genetic polymorphisms and Helicobacter pylori infection in the development of gastric cancer. Aliment Pharmacol Ther (2004) 0.92
The biology of cag in the Helicobacter pylori-human interaction. Gastroenterology (2005) 0.90
[Changes of gastric mucosa histopathology after Helicobacter pylori eradication]. Zhonghua Nei Ke Za Zhi (2003) 0.77
[Gastric carcinoma]. Internist (Berl) (2000) 0.77
Diagnosis and Treatment of Helicobacter pylori. Curr Treat Options Gastroenterol (2005) 0.76
CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology (2006) 2.39
Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis (2003) 1.80
Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. Gastroenterology (2009) 1.57
Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology (2007) 1.49
Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology (2007) 1.46
Human dendritic cells respond to Helicobacter pylori, promoting NK cell and Th1-effector responses in vitro. J Immunol (2004) 1.35
Toll-like receptor-dependent activation of antigen-presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology (2007) 1.23
Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol (2005) 1.21
In vivo histopathology of lymphocytic colitis. Gastrointest Endosc (2007) 1.07
Helicobacter pylori induces apoptosis of rat gastric parietal cells. Am J Physiol Gastrointest Liver Physiol (2002) 0.95
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks. Gastroenterology (2011) 0.94
Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination. Trends Microbiol (2003) 0.93
A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology (2005) 0.92
Vascular endothelial growth factors, angiogenesis, and survival in human ileal enterochromaffin cell carcinoids. Neuroendocrinology (2009) 0.80
Two cases of primary pulmonary angiosarcoma as a rare cause of lung haemorrhage. Pathology (2011) 0.80
VacA-associated inhibition of T-cell function: reviewed and reconsidered. Helicobacter (2006) 0.79
Current trends in the treatment of upper gastrointestinal disease. Best Pract Res Clin Gastroenterol (2002) 0.78
In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis. World J Gastroenterol (2008) 0.77